NeuroPace, Inc.
NPCENASDAQHealthcare● Active
$15.63
$-0.11(-0.70%)
Market Cap$532885234
P/E Ratio—
52W High$19.6
52W Low$7.563
NeuroPace, Inc. (NPCE) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NPCE · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $99.99M | $79.91M | $65.42M | $45.52M | $45.18M |
| Cost of Revenue | $22.77M | $20.82M | $17.30M | $13.03M | $11.75M |
| Gross Profit | $77.22M | $59.09M | $48.12M | $32.49M | $33.44M |
| Gross Margin %(computed) | 77.23% | 73.94% | 73.56% | 71.38% | 74.00% |
| Operating Expenses | |||||
| R&D Expenses | $27.89M | $23.65M | $20.78M | $21.95M | $18.21M |
| G&A Expenses | $19.09M | $17.43M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $93.56M | $80.76M | $75.30M | $73.29M | $57.17M |
| Operating Income | ($16.34M) | ($21.67M) | ($27.17M) | ($40.79M) | ($23.74M) |
| Operating Margin %(computed) | -16.34% | -27.12% | -41.54% | -89.62% | -52.54% |
| Interest Income | $2.82M | $3.02M | $3.05M | $1.58M | $0.45M |
| Interest Expense | $7.46M | $8.80M | $8.52M | $7.53M | $7.41M |
| Income Before Tax | ($21.46M) | ($27.14M) | ($32.96M) | ($47.08M) | ($36.08M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($21.46M) | ($27.14M) | ($32.96M) | ($47.08M) | ($36.08M) |
| Net Margin %(computed) | -21.47% | -33.97% | -50.38% | -103.43% | -79.85% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.66 | $-0.93 | $-1.27 | $-1.91 | $-2.17 |
| Wtd Avg Shares | 32.72M | 29.13M | 25.85M | 24.59M | 16.61M |
| EBITDA | ($14.39M) | ($16.57M) | ($22.83M) | ($36.57M) | ($28.37M) |
| EBITDA Margin %(computed) | -14.39% | -20.74% | -34.90% | -80.33% | -62.80% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more NeuroPace, Inc. data
About NeuroPace, Inc. (NPCE) Income Statement
NeuroPace, Inc. (NPCE) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, NPCE reported revenue of $0.10B, gross profit of $0.08B (gross margin 77.23%), and net income of ($0.02B) — a net profit margin of -21.47%.
Frequently asked questions
NPCE · 4 questionsNeuroPace, Inc. (NPCE) reported revenue of $0.10B for 2025, up 25.1% year-over-year.
NPCE revenueNPCE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08